Hsbc Holdings PLC Buys Shares of 7,809 National HealthCare Corporation $NHC

Key Points

• HSBC Holdings PLC acquired 7,809 shares of National HealthCare Corporation in the second quarter, valued at approximately $1.64 million. Institutional investors and hedge funds collectively own 56.44% of NHC.
• Analyst sentiment is broadly positive: Goldman Sachs and Robert W. Baird upgraded NHC to “strong buy,” while BMO Capital Markets and RBC raised their ratings to “hold.” MarketBeat lists the stock’s average rating as “Buy.”
• NHC reported quarterly earnings of $1.74 per share on $408.03 million in revenue and announced a quarterly dividend of $0.67, equivalent to a 1.2% yield. The stock recently opened at $222.70, near its 52-week high of $239.29.

Hsbc Holdings PLC acquired a new stake in shares of National HealthCare Corporation (NYSEAMERICAN:NHC - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 7,809 shares of the company's stock, valued at approximately $1,639,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Allworth Financial LP purchased a new position in National HealthCare in the 2nd quarter worth $27,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in National HealthCare in the second quarter valued at approximately $37,000. Caitong International Asset Management Co. Ltd purchased a new stake in National HealthCare during the third quarter worth $25,000. Quarry LP boosted its position in National HealthCare by 171.9% during the third quarter. Quarry LP now owns 261 shares of the company's stock worth $32,000 after purchasing an additional 165 shares in the last quarter. Finally, Kestra Advisory Services LLC acquired a new stake in National HealthCare in the 4th quarter valued at $42,000. 56.44% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

NHC has been the subject of several recent research reports. BMO Capital Markets raised National HealthCare to a "hold" rating in a research note on Monday, May 18th. The Goldman Sachs Group upgraded National HealthCare to a "strong-buy" rating in a report on Monday, May 18th. Robert W. Baird raised shares of National HealthCare to a "strong-buy" rating in a research note on Monday, May 18th. Finally, Royal Bank Of Canada raised National HealthCare to a "hold" rating in a research note on Monday, May 18th. Two equities research analysts have rated the stock with a Strong Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Buy".

National HealthCare Price Performance

NYSEAMERICAN:NHC opened at $222.70 on Monday. National HealthCare Corporation has a 1-year low of $111.24 and a 1-year high of $239.29. The firm's fifty day moving average price is $219.36 and its 200 day moving average price is $190.08. The firm has a market cap of $3.49 billion, a price-to-earnings ratio of 25.05 and a beta of 0.61.

National HealthCare (NYSEAMERICAN:NHC - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $1.74 earnings per share for the quarter. National HealthCare had a return on equity of 10.03% and a net margin of 9.00%.The firm had revenue of $408.03 million for the quarter.

National HealthCare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 1.2%. The ex-dividend date is Wednesday, September 30th. National HealthCare's dividend payout ratio is presently 61.89%.

Insider Transactions at National HealthCare

In other National HealthCare news, Director David R. Gifford sold 1,779 shares of the firm's stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $225.42, for a total value of $401,022.18. Following the transaction, the director directly owned 1,030 shares of the company's stock, valued at $232,182.60. This trade represents a 63.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Stephen Fowler Flatt sold 1,500 shares of the business's stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $237.08, for a total transaction of $355,620.00. Following the completion of the transaction, the chief executive officer owned 65,487 shares in the company, valued at $15,525,657.96. This represents a 2.24% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 13.92% of the company's stock.

National HealthCare Company Profile

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source